Faulkner Amanda L, Bacon James David, Fischer Brian A, Grupke Stephen L, Hatton Kevin W
Department of Anesthesiology, N-202 UKMC, 800 Rose Street, Lexington, KY 40536, USA.
Department of Neurosurgery, 800 Rose Street, Lexington, KY 40536, USA.
Case Rep Neurol Med. 2019 Jul 10;2019:9537453. doi: 10.1155/2019/9537453. eCollection 2019.
Extracorporeal membrane oxygenation (ECMO) is an important life-saving technology for patients with severe acute respiratory distress syndrome (ARDS). Unfortunately, ECMO has been traditionally contraindicated in patients with hemorrhagic neurologic diseases. The recent improvement in ECMO devices, increased utilization and experience with venovenous ECMO technologies among healthcare teams, and the use of ECMO without anticoagulation has expanded the potential populations that may benefit from ECMO. We present a case of successful utilization of venovenous ECMO for severe respiratory failure secondary to ARDS in a patient with aneurysmal subarachnoid hemorrhage and severe, episodic cerebral vasospasm. We also discuss important limitations and considerations for future successful use of ECMO in hemorrhagic stroke. This case report highlights the potential for this life-saving technology in patients with hemorrhagic stroke.
体外膜肺氧合(ECMO)是治疗严重急性呼吸窘迫综合征(ARDS)患者的一项重要的挽救生命的技术。不幸的是,传统上ECMO在患有出血性神经系统疾病的患者中是禁忌的。近年来,ECMO设备的改进、医疗团队对静脉-静脉ECMO技术的更多使用和经验,以及无抗凝的ECMO使用,扩大了可能从ECMO中获益的潜在人群。我们报告了1例成功使用静脉-静脉ECMO治疗1例患有动脉瘤性蛛网膜下腔出血和严重发作性脑血管痉挛患者继发于ARDS的严重呼吸衰竭的病例。我们还讨论了未来在出血性卒中成功使用ECMO的重要局限性和注意事项。本病例报告突出了这项挽救生命技术在出血性卒中患者中的应用潜力。